Pan-RAS Biology Research Solutions
Complete research tools for RAS signaling — from upstream activators through every RAS isoform to downstream effectors.
Clones | Recombinant Proteins | WB control Lysates | Antibodies | CytoSection
The RAS field is shifting from mutation-specific inhibitors (Sotorasib, Adagrasib) to Pan-RAS strategies targeting all three isoforms. OriGene provides the complete toolset — ORF clones, recombinant proteins, antibodies, overexpression lysates, CytoSections (IHC/ICC/IF control) and reporter assays — to study RAS signaling across KRAS, NRAS, and HRAS.
Click a gene on the map to filter the products below.
SRE, AP1 & FOXO luciferase reporter assays
Monitoring the activity of the pan-RAS pathway in a cellular model has never been easy.
Detection of EV-associated KRAS mutations as a prognostic biomarker
Plasma EVs from pancreatic ductal adenocarcinoma (PDAC) patients were isolated using the MagExo™ EV Isolation Kit. EV-derived DNA was analyzed by droplet digital PCR (ddPCR) to quantify KRAS mutations, demonstrating that EV-associated KRAS can serve as a minimally invasive biomarker for PDAC prognosis, disease monitoring, and patient stratification.
Learn more here →Absolute quantification of KRAS by automated Simple Western
See how OriGene's purified KRAS protein (TP301958) and anti-KRAS antibody (TA801672) enabled absolute quantification of KRAS from various cell lines using the automated WB Simple Western platform.
View AACR '26 Poster →Don't see what you need?
Contact us for the targets you don't see or any customization request — our team will help you get started.
